Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Build a KOL Community Virtually – Engaging Your Advisors Creatively

Go beyond formal meetings! Discover a creative way to build a virtual KOL community through ongoing discussion forums. Facilitate peer-to-peer best practice sharing and foster authentic, sustained relationships with your...

Impetus Digital

- PMLiVE

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Bedrock Healthcare Communications

- PMLiVE

MHRA and FDA expand collaboration on AI and medtech regulation

National Commission on the Regulation of AI in Healthcare brings together UK and US experts

- PMLiVE

Lilly appoints former US FDA director Peter Marks to lead infectious disease division

Marks joins the drugmaker after resigning from the FDA in March

- PMLiVE

Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030

[Dublin, 9th October 2025] Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based Targets initiative (SBTi) goal of halving Scope 1 and...

Uniphar

- PMLiVE

Delivering purposeful solutions at Obesity Week 2025

We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

Inizio

- PMLiVE

Speak up to step forward

Why the employee voice deserves more than lip service

- PMLiVE

Pfizer’s Lorviqua recommended by NICE for lung cancer

Lung cancer is the leading cause of cancer-related deaths worldwide

- PMLiVE

Prime welcomes James Karcher to senior leadership team

Karcher has been appointed as global EVP, Medical Communications, AI and Digital Healthcare

- PMLiVE

Driving launch excellence with agile transformation

Examining the key risks and opportunities that biopharma asset teams should prioritise during R&D and launch

Amiculum - science that speaks volumes

New brand, same great team!

We’re excited to launch our refreshed Amiculum visual identity today. Our new brand encapsulates the vibrancy and creativity that we see every day from our team. It’s fresh, forward-looking and...

Amiculum

- PMLiVE

New study highlights global overuse of antibiotics for diverticulitis

Researchers warn that excessive antibiotic use in diverticulitis increases risk of antimicrobial resistance and unnecessary hospital admissions

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links